| HOME >> BIOLOGY >> TECHNOLOGY |
TORONTO, Oct. 19 /PRNewswire-FirstCall/ - ARIUS Research Inc., (TSX: ARI), a biotechnology company discovering and developing the next wave of antibody therapeutics, today announced that David Young, MD, President and Chief Executive Officer of ARIUS, will speak at the Chinese Global Financial Forum. Dr. Young will present on Saturday October 20th at 3:25 p.m. and will be available prior to and following his presentation at booth #706. The conference is being held at the Hilton Suites Toronto/Markham Conference Centre & Spa. Dr. Young will provide an overview of ARIUS' business and will update the audience on milestones for the Company's lad programs in cancer.
About ARIUS
ARIUS is a biotechnology company discovering and developing the next wave of antibody therapeutics. Established in 1999, ARIUS has built a proprietary technology platform, FunctionFIRST(TM), that rapidly identifies and selects antibodies based on their functional ability to affect disease. This antibody generation engine has enabled ARIUS to assemble a portfolio of more than 400 antibody candidates. In addition to the antibodies it is developing in-house, ARIUS has ongoing partnerships with key biotechnology and drug development companies. ARIUS is listed on the TSX under the symbol "ARI". For further information, visit http://www.ariusresearch.com
Forward-Looking Statements
Certain statements in this news release constitute "forward-looking
statements" within the meaning of the Private Securities Litigation Reform
Act of 1995, which involve known and unknown risks, uncertainties and other
factors that may cause our actual results to be materially different from
any future results, performance or achievements expressed or implied by
such statements. Forward-looking statements in this release include, but
are not limited to, ARIUS successfully advancing its new product programs
as well as licensing opportunities
'/>"/>
| SOURCE ARIUS Research Inc. Copyright©2007 PR Newswire. All rights reserved |